Navigation Links
Studies Probe Weaknesses in Donated Blood
Date:10/8/2007

It's never as good as the body's own at delivering oxygen to tissue, researchers say

MONDAY, Oct. 8 (HealthDay News) -- Researchers have spotted a chemical deficiency that renders donated blood stored in blood banks less effective at delivering oxygen to tissues, compared to fresh blood.

But in a second study, the same group of scientists may have also found a way to remedy the problem.

Though unlikely to change current clinical practice in the short term, the findings help explain why, in many cases, blood transfusions do more harm than good by boosting risks for heart attack, organ failure and even death, experts say.

The studies "reinforce that conservatism [in giving transfusions] is important," said Dr. Louis Katz, executive vice president for medical affairs at the Mississippi Valley Regional Blood Center in Davenport, Iowa, and past president of America's Blood Centers, a network of community blood banks. "First, do no harm -- don't transfuse unless you must," he said. Katz was not involved in either study.

Both reports were published this week in the early online edition of the Proceedings of the National Academy of Sciences.

In one study, Drs. Jonathan Stamler and Timothy McMahon, of Duke University Medical Center in Durham, N.C., led research teams that independently examined the ability of fresh and banked human blood to serve its medical purpose -- to increase oxygen availability to tissues that need it.

This activity is based on two parameters -- how much oxygen, and how much nitric oxide the red blood cells hold. Nitric oxide (NO) is a vasodilator -- a compound that opens (dilates) blood vessels. It is carried in red blood cells by hemoglobin, the oxygen-delivering protein that gives red blood cells their color. When hemoglobin encounters a tissue with relatively little oxygen, it releases NO, thereby causing blood vessels to open and ease the red cells' entry into the tissue, where they can release their oxygen.

Stamler and McMahon (previously a student in Stamler's lab) found that stored blood rapidly loses the bulk of its NO within three hours of collection. Its ability to induce vasodilation likewise diminishes, they said.

"Everybody thinks if you give back oxygen-carrying red blood cells, you will get more oxygen to tissues," said Stamler. "No, that's not the case. The blood we give cannot open vessels, and thus cannot deliver oxygen, and we think that's because it's missing nitric oxide gas."

The researchers also found that stored red cells gradually lose their "membrane flexibility" -- a physical attribute of red cells that allows them to squeeze into narrow capillaries, and which may also be related to NO depletion.

Some five million patients receive blood transfusions annually in the United States, amounting to almost 14 million units of blood, according to a 2005 report.

Yet, except in cases of trauma, there are few guidelines on exactly who should receive blood transfusions, and little agreement over how much they should get. Existing clinical trial data, mostly in the form of retrospective analyses, suggest that, if anything, giving blood may harm patients more than it helps them.

"Overall, the [previous clinical] trials have shown that while bleeding is bad, and while decreases in blood count is bad, giving blood back is not good -- that's the paradox," explained Stamler. He said extensive data exists to support an association between blood transfusions and elevated risk of heart attack, organ damage, and death.

The new studies provide a molecular rationale for these observations. Not only can NO-depleted, stored red blood cells not open blood vessels, they may actually block capillaries in already oxygen-starved tissues, exacerbating tissue damage. Furthermore, donated blood cells may act as a "sink" to soak up NO, thereby causing vessels to contract and become even more impassible.

"This [study] is an important reminder that while transfusions are lifesaving in some settings, there are also settings where we know patients do better with a restrictive transfusion strategy," McMahon said.

According to Katz, the results must now be replicated in controlled clinical trials. "If it is true, it raises the question of, are there things we can do in the bag [of donated blood] that would make this not a problem? Can you put nitric oxide in the bag?"

Stamler's group addressed that challenge in a study conducted with dogs. They found that human red cells' vasodilatory activity could be restored at any point up to 40 days following collection by treatment with NO, thereby improving blood flow to the heart in blood recipients.

"The hope would be that this will also work in humans," Stamler said. "We already know that the blood we give people is not normal and that it cannot open vessels properly. Our hope is if we put the nitric oxide back in, we could cure this problem."

In the meantime, those patients in need of a blood transfusion would do well to stay informed, Katz said. "The bottom line on transfusion is to ask what is the functional benefit of transfusion in this patient at this time," he said. "We (docs) are often guessing, but good docs make good guesses."

Both Stamler and McMahon noted conflicts of interest in their reports, including grant support and consulting fees from, and equity holdings in, Nitrox/N30 Pharma, "a company that is developing strategies for treating disorders of oxygen delivery," according to Stamler's manuscript.

More information

For more on blood transfusions, visit the U.S. National Library of Medicine.



SOURCES: Jonathan S. Stamler, M.D., departments of medicine and biochemistry, Duke University Medical Center, Durham, N.C.; Timothy J. McMahon, M.D., Ph.D., department of medicine, Duke University Medical Center, Durham, N.C.; Louis M. Katz, M.D., executive vice president, Medical Affairs, Mississippi Valley Regional Blood Center, Davenport, Iowa, and past president, America's Blood Centers; Oct.8-12, 2007, online edition, Proceedings of the National Academy of Sciences


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Studies On Hearing Loss Discovers New Causes
2. Broccoli Found to Block Cancer Progression In Both Animal and Human Studies
3. Studies Advocate Natural Form Of Vitamin E
4. Cure For Autism Could Be Established Through Hamster Studies
5. Despite More Studies Researchers Are Still Confound With ADHD
6. Studies Show Brain becomes Less Specialized With Age
7. ISB To Establish Research Chair On Real Estate And Urban Studies
8. Studies Show Combination Drugs As A Poor Substitute For Anti-Coagulants In Stroke
9. Further Studies Needed To Completely Understand About Ventricular Fibrillation
10. Studies Report Mammograms Unsafe
11. Six Indians Win Australian Studies Fellowships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping ... fitness app. The fitness app plans to fix the two major problems leading the fitness ... size fits all type program , They don’t eliminate all the reasons people ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology: